MARKET VIEW FOR THE WEEK 18TH APRIL 2011 TO 22ND APRIL 2011

Note: Attention all members and visitors:

Kindly keep checking the blog after 12 PM daily as there will be stock ideas and updates after 11.00am to get the HOT PICK

SENSEX ENDED AT 19386.82 & NIFTY AT 5824.55 AFTER THE RESULTS OF INFOSYS. AS THE MARKET IS IN INTERMEDIATE UP TREND FALL FROM 11TH APRIL IS CORRECTION TO THE TREND.NOW THE RANGE IS 5700 TO 5900.MARKET WILL BE STRONG ABOVE 5900 BUT WEAK BELOW 5700. HENCE THE MARKET WILL BE IN A RANGE WITH SIDE WAYS MOVEMENT AND WHEN THE SUBSTANTIAL PART OF EARNING SEASON IS OVER, MARKET WILL TAKE FRESH DIRECTION FROM OTHER CUES LIKE INFLATION, INTEREST RATE ETC., RBI MEET ON 3RD MAY, CRUDE PRICES AND GEO POLITICAL SITUATION WILL ALSO AFFECT THE MARKET SENTIMENT AND MOOD FROM TIME TO TIME.

HOWEVER IT IS IMPORTANT TO KEEP IN MIND THAT THERE PERSISTS A SKEPTICISM ABOUT THE CONCERNS ON INTERST RATE AND CRUDE PRICES AND ITS IMPACT ON THE INDIAN ECONOMY IN THE INTERMEDIATE TERM. IN A VERY SHORT TERM LIQUIDITY MAY DRIVE THE MARKET AND CHASE THE STOCK PRICES UP, BUT GLOBAL RISK AVERSION, CONCERNS IN AMERICAN ECONOMY SHALL KEEP THE MARKETS ALWAYS IN WORRIES. THIS WEEK IMPORTANT GLOBAL EVENTS TO WATCH ARE U.S ECONOMIC DATA LIKE: MARCH HOME SALES DATA, MARCH RETAIL SALES DATA, JOBLESS CLAIM DATA & BoE POLICY MEET. DOMESTICALLY RELIANCE INDUSTRIES AND OTHER CORPORATE RESULTS SHALL BE THE FOCUS OF THE WEEK. 

MERGERS & ACQUISITIONS HAVE MARKED THE MARKET WITH WHAT PROSPECTIVE GROWTH AND POTENTIALS OF LONG TERM STORY  IN INDIA STORES. HENCE AN INFORMED INVESTOR WILL HAVE GOLDEN OPPORTUNITY TO TAP THE TREMENDOUS GROWTH IN INDIAN STOCK MARKET. 

RELIANCE RESULTS WILL BE GOOD AS GRMs SEEN STRONG BUT THE SHARE PRICE MAY NOT OUT PERFORM DUE TO SOME OTHER REASONS. FMCG IS LOOKING GOOD FOR THE SHORT TERM AND PHARMA SHOULD BE AVOIDED AS THERE MAY BE SOME CORRECTION IN THIS SECTOR. HOWEVER SOME PHARMA STOCKS WILL BE A GOOD PICK FOR LONG & MEDIUM TERM INVESTMENT.

FOLLOWING STOCKS ARE RECOMMENDED FOR TRADING & INVESTING FOR MEDIUM TERM(3-4 MONTHS):

1.BHUSHAN STEEL(517.55): BUY THIS STOCKS AT CMP OR AT DECLINE FOR A TARGET OF 540-550++++

2. INDUSIND BANK(279.70):BUY THIS STOCKS AT CMP OR AT DECLINE FOR A TARGET OF 300-310+++

3. DCB(58.85):BUY THIS STOCKS AT CMP OR AT DECLINE FOR A TARGET OF 75+++ ( A VERY BIG INVESTOR HAS STARTED BUYING IN THIS COUNTER. A GOOD BET FOR LONG TERM)

4.HATHWAY CABLE(119.35):BUY THIS STOCKS AT CMP OR AT DECLINE FOR A TARGET OF 140-150+++(SOME GOOD NEWS FLOW)

5.TIMKEN INDIA(206.50): THERE IS A DELISTING MEET ON 22ND APRIL @320/SHARE. THE STOCK MAY RISE TO 250 IN SHORT TERM. DELISTING MAY TAKE TIME OF 3-4 MONTHS.

6. CAMLIN(75.80): STOCK HAS A BUZZ OF PROMOTER SELLING STAKE IN THE COMPANY @101/SHARE FOR EXPANSION. THIS MAY MORE TRIGGER TO THE STOCK IN DAYS TO COME. ( WE HAVE RECOMMENDED THIS STOCK @54-52 A MONTH EARLIER.

7.PETRONET(133.80):BUY THIS STOCKS AT CMP OR AT DECLINE FOR A TARGET OF 140-145++++ VERY SOON.

8.IFB AGRO(80.60):BUY THIS STOCKS AT CMP OR AT DECLINE FOR A TARGET OF 90++

9. KSB PUMPS(560.70):BUY THIS STOCKS AT CMP OR AT DECLINE FOR A TARGET OF 580-600

10. STERLITE TECH(67.75):BUY THIS STOCKS AT CMP OR AT DECLINE FOR A TARGET OF 80+++ VERY SOON. WE HAVE EARLIER RECOMMENDED IT AT 45-48.

11. JP ASSOCIATE(99.50): BUY THIS STOCKS AT CMP OR AT DECLINE FOR A TARGET OF 110-115++++

12. D-LINK(36.35):BUY THIS STOCKS AT CMP OR AT DECLINE FOR A TARGET OF 50++++. SMART LINK WILL BUY SOME D-LINK PROMOTER'S STAKE AT Rs50/ SHARE.

13. ITC(191.40): BUY THIS STOCKS AT CMP OR AT DECLINE FOR A TARGET OF 200-210+++ VERY SOON. SPECULATORS MAY BUY MAY SERIES CE190 & CE200.

14.TORRENT PHARMA(587.40):BUY THIS STOCKS AT CMP OR AT DECLINE FOR A INVESTMENT TARGET OF 650-700-750-1000+++. A VERY GOOD PICK IN PHARMA SPACE. RECOMMENDING EVEN AFTER PHARMA SECTOR LOOKS WEAK AHEAD. BUT THIS STOCK IS WORTH BUYING FOR INVESTMENT PURPOSE, WHICH MAY PROVE MULTI-BAGGER.

Safe Harbor Statement:
Some forward looking statements on projections, estimates, expectations & outlook are included to enable a better comprehension of the Company prospects. Actual results may, however, differ materially from those stated on account of factors such as changes in government regulations, tax regimes, economic developments within India and the countries within which the Company conducts its business, exchange rate and interest rate movements, impact of competing products and their pricing, product demand and supply constraints.Nothing in this article is, or should be construed as, investment advice.

Disclaimer: 
This is neither an offer nor a solicitation to purchase or sell securities. The information and views contained on this blog are believed to be reliable, but no responsibility (or liability) is accepted for errors of fact or opinion. Writers and contributors may be trading in, or have positions in the securities mentioned in their articles. Neither I (Vikas Srivastava) nor any of the contributors accepts any liability arising out of use of the above information/article. Reproduction in whole or in part without written permission is prohibited.